Journal Guide

Discover Sustainability is part of the Discover journal series committed to providing a streamlined submission process, rapid review and publication, and a high level of author service at every stage. It is a multi-disciplinary, open access, community-focussed journal publishing results from across all fields relevant to sustainability research.

The journal publishes original research findings (and reviews solicited by the Editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or with abnormal tissue distribution. This journal is designed to provide a forum for publications dealing with original observations in this developing field on any aspect of the general topic including: * Identification of new genetic or non-genetic markers (e.g., cell-surface antigens, serum proteins, intra- and extra-cellular enzymes, cytogenic markers and DNA-sequences) * Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states * Amplification of knowledge about existing markers * Family studies of markers in disease * New techniques for identification and/or isolation of important marker molecules * Use of monoclonal antibodies for the definition of molecular structures associated with disease markers * Identification of disease-associated abnormalities in DNA using recombinant DNA techniques, gene-cloning and DNA restriction enzyme fragment polymorphisms * Identification of markers identifying malignantly transformed neoplastic cells.

Disease Models & Mechanisms (DMM) is an Open Access biomedical research journal focusing on the use of model systems to better understand, diagnose and treat human disease. The primary aim of DMM is to promote human health by inspiring collaboration between basic and clinical researchers in translational science. The journal is committed to presenting rigorously peer-reviewed research that has significant translational impact. The interdisciplinary nature of DMM means that a diverse range of diseases, approaches and models fall within its broad scope. DMM is guided by an international team of expert research-active Editors, led by Editor-in-Chief Elizabeth Patton and Deputy Editor-in-Chief Elaine Mardis, and supported by an outstanding Editorial Advisory Board.

Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.

Doklady Biochemistry and Biophysics presents English translations of current Russian research from the biochemistry and biophysics sections of the Doklady akademii nauk (Proceedings of the Russian Academy of Sciences). The Proceedings appear 36 times per year; articles on biochemistry and biophysics are collected, translated, and published in 6 issues per year. Doklady Biochemistry and Biophysics publishes the most significant new research in biochemistry and biophysics being done in Russia today, thus ensuring its scientific priority. Since 2001, the journals Doklady Biochemistry and Doklady Biophysics have been combined.

Doklady Biological Sciences is a journal containing English translations of current Russian research in molecular biology, cell biology, microbiology, immunology, physiology, general biology and botanics, published in the corresponding sections of the Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences). The Proceedings appear 36 times a year, articles from the selected biological sections are collected, translated, and published in 6 issues a year. Doklady Biological Sciences publishes the most significant new research in the biological sciences being done in Russia today, thus ensuring its scientific priority.The Editorial Board of Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences) accepts new articles in the Russian language, formatted in accordance with the Rules for Authors. The article must be presented for publication by acting Russian or foreign members of the Russian Academy of Sciences.

Domestic Animal Endocrinology publishes scientific papers dealing with the study of the endocrine physiology of domestic animal species. Those manuscripts utilizing other species as models for clinical or production problems associated with domestic animals are also welcome.Topics covered include:Classical and reproductive endocrinologyClinical and applied endocrinologyRegulation of hormone secretionHormone actionMolecular biologyCytokinesGrowth factorsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The Drug Discovery Today reviews collection provides a resource of review content aligning the key output of human molecular medicine with the specific requirements of the drug discovery process. It is designed to systematically cover the essential elements of molecular medicine and drug discovery, in a manner that has relevance to those actually working on the discovery and development of new drugs. This collection will evolve to create a highly structured database and will act as a one-stop-shop for high quality content.Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.Other titles in this series include:Drug Discovery Today: Disease MechanismsDrug Discovery Today: Therapeutic StrategiesDrug Discovery Today: TechnologiesThere will be four issues each year.The Drug Discovery Today reviews collection is only available online.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest

Drug Metabolism Letters publishes letters, original research articles, mini-reviews, thematic issues based on mini-reviews and letters, commentaries, technical notes and drug clinical trial studies on major advances in all areas of drug metabolism and disposition.

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease *Describes emerging technologies and therapies, particularly those that overcome drug resistance *Emphasises common themes in microbial and cancer research

The Dubai Diabetes and Endocrinology Journal welcomes original contributions on all aspects of diabetes, endocrinology, and metabolism. Taking into account that diabetes has become a pandemic, the journal provides a platform for worldwide communication and scientific exchange to researchers and clinicians dealing with diabetes. The focus of the journal lies on the publication of papers on morphological, biochemical, physiological, pathophysiological, and clinical aspects of research on diabetes and metabolism. In addition to research articles, further types of papers such as review articles, case reports, reviews, meta-analyses, letters, editorials, and commentaries make the journal a comprehensive and interesting read. The researcher and practitioner who seeks to stay up to date on the developments in the fields of diabetes and metabolism will find a wealth of information in the Dubai Diabetes and Endocrinology Journal.

The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

As the communities that border this interface are large and diverse, the scope of EBioMedicine will cover the entire breadth of translational and clinical research within all disciplines of life and health sciences, ranging from basic science to clinical and public/global health science. The journal will also place a high priority on rapid publication. The journal seeks to publish a broad range of research study types, from experimental findings, critical analyses, methodological & technical innovations, and hypotheses to observational epidemiological studies, clinical trials, meta-analyses, and study protocols. In addition, EBioMedicine will publish commentaries, reviews, and viewpoints that enhance the accessibility and applicability of basic research findings for health professionals, and promote a better understanding of clinical challenges for biomedical researchers.

In leveraging the editorial leadership from Cell and The Lancet together with the publishing expertise of Elsevier to create a unique forum for the reputable and speedy publication of research in life and health sciences, we are committed to facilitating and incentivizing a robust and successful pipeline for improved human health globally.

ELECTROPHORESIS is an international journal that publishes original manuscripts on all aspects of electrophoresis. Topics include new or improved analytical and preparative methods, development of theory, and innovative applications of electrophoretic methods in the study of nucleic acids, proteins, and other compounds. Papers describing the application of standard electrophoretic methods will not be considered. Microfluidics and proteomics, which have been an integral part of the Journal since 2000 or earlier, have been added as subtitles in 2008 to make them more visible to the readers and authors (Papers in the areas of microfluidics and proteomics, which are not limited to electrophoresis-based methods will also be accepted for publication). As a natural expansion of the scope of the Journal, we now add Nanoanalysis as another subtitle. Nanoanalysis is a broad term, and therefore papers that will be accepted for publications in nanoanalysis must be focused on one or more of the following: (i) nanoscale electrokinetics and phenomena related to electric double layer and/or confinement in nano-sized geometry, (ii) single cell and sub- cellular analysis, (iii) nano-sensors and ultra-sensitive detection aspects (e.g., involving quantum dots, 'nano-electrodes' or nano-spray MS), (iv) nano-scale/nanopore DNA sequencing (next generation sequencing), (v) micro- and nano-scale sample preparation, (vi) nanoparticles and cells analyses by dielectrophoresis, (vii) separation-based analysis using nanoparticles, nanotubes and nanowires. Contributions will be allocated to one of the six subject categories: (i) general, (ii) nucleic acids, (iii) capillary electrophoresis and capillary electrochromatography (CE and CEC), (iv) microfluidics and miniaturization, (v) proteomics and two-dimensional electrophoresis (2-DE), and (vi) nanoanalysis. On submission authors are requested to indicate the preferred subject category. ELECTROPHORESIS will continue to serve as an indispensable vehicle for the dissemination of efficacious advances by covering all operative approaches from gels through capillaries to chips. Upcoming Special Issues:

The journal publishes original research reports, authoritative reviews and case reports of experimental and clinical sciences.

Topics include:

• metagenomics
• population genetics/genomics
• evolutionary ecology
• conservation and molecular adaptation
• speciation genetics
• environmental and marine genomics
• ecological simulation
• genomic divergence of organisms

Physiological and Biochemical Zoology has since 1928 presented current research in environmental, adaptational, and comparative animal physiology and biochemistry. PBZ publishes the results of original investigations in animal physiology and biochemistry at all levels of organization, from the molecular to the organismic, focusing on adaptations to the environment. PBZ covers a wide range of subdisciplines, with a specific emphasis on studies that investigate the ecological and/or evolutionary aspects of physiological and biochemical mechanisms.